Technology in Cancer Research & Treatment (Oct 2023)

Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know

  • Pejman Jabehdar Maralani MD, FRCPC,
  • Rachel W. Chan PhD,
  • Wilfred W. Lam DPhil,
  • Wendy Oakden PhD,
  • Ryan Oglesby PhD,
  • Angus Lau PhD,
  • Hatef Mehrabian PhD,
  • Chris Heyn MD, PhD,
  • Aimee K.M. Chan MSc,
  • Hany Soliman MD,
  • Arjun Sahgal MD,
  • Greg J. Stanisz PhD

DOI
https://doi.org/10.1177/15330338231208613
Journal volume & issue
Vol. 22

Abstract

Read online

Chemical exchange saturation transfer (CEST) is a relatively novel magnetic resonance imaging (MRI) technique with an image contrast designed for in vivo measurement of certain endogenous molecules with protons that are exchangeable with water protons, such as amide proton transfer commonly used for neuro-oncology applications. Recent technological advances have made it feasible to implement CEST on clinical grade scanners within practical acquisition times, creating new opportunities to integrate CEST in clinical workflow. In addition, the majority of CEST applications used in neuro-oncology are performed without the use gadolinium-based contrast agents which are another appealing feature of this technique. This review is written for clinicians involved in neuro-oncologic care (nonphysicists) as the target audience explaining what they need to know as CEST makes its way into practice. The purpose of this article is to (1) review the basic physics and technical principles of CEST MRI, and (2) review the practical applications of CEST in neuro-oncology.